<DOC>
	<DOCNO>NCT03103620</DOCNO>
	<brief_summary>A multi-center , prospective , consecutive enrol , observational registry . The population study include patient undergoing treatment `` de novo '' lesion native coronary vessel , saphenous vein graft and/or arterial bypass conduit COBRA PzF coronary stent system . The registry primarily assess rate MACE ( cardiac death , myocardial infarction clinically drive target lesion revascularization .</brief_summary>
	<brief_title>Safety Effectiveness Evaluation COBRA PzF Coronary Stent System : A Post Marketing Observational Registry</brief_title>
	<detailed_description />
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina , Unstable</mesh_term>
	<mesh_term>Angina , Stable</mesh_term>
	<criteria>Patient give oral consent participate registry Patient implant COBRA PzF stent Target lesion ( ) is/are `` de novo '' Pregnancy Age &lt; 18 year Refusal inability give oral consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>